Immune Monitor - January 2018

A Message from the President

Dear Colleagues,

This month, I wanted to update you all on some of the ways that the society fulfills its mission. As a reminder, the mission of the Society for Immunotherapy of Cancer (SITC) is to improve cancer patient outcomes by advancing the science, development and application of cancer immunology and immunotherapy.

The SITC Annual Meeting advances the society's mission through the rapid dissemination of important research that pushes the field forward. For example, SITC member Vinod Balachandran, MD, who received the Presidential Award at SITC 2017 for his presented work identifying neoantigen factors or qualities associated with long-term survival in patients with pancreatic cancer, recently published those data across two high profile manuscripts in Nature. Juno Therapeutics, Inc. recently published important CAR T therapy guidance in Cancer Discovery, based on results also presented at SITC 2017, characterizing toxicities associated with JCAR015 therapy in adult patients with B-ALL. Also, SITC member Jason Luke, MD, FACP recently published data that he presented at SITC 2017 in Cancer Discovery concerning safety and efficacy of combination anti-PD-1 nivolumab and the investigational indoleamine 2,3-dioxygenase 1 inhibitor BMS-986205 in patients with bladder and cervical cancers. It's exciting to know that the SITC Annual Meeting provided a forum for oral presentation of these data sets. These presentations and subsequent manuscripts were further highlighted in other journals.

Another approach for accomplishing our mission, SITC is continuously working to create unique opportunities for individuals to conduct meaningful scientific exchange that lead to advances and recommendations in research and clinical care. An example of this was recently highlighted in The Washington Post. Our society's members worked for months through a multi-stakeholder process to generate and publish consensus recommendations on the management of toxicities associated with immune checkpoint inhibitors in the Journal for ImmunoTherapy of Cancer (JITC). Efforts like these will benefit clinicians and translational researchers by improving the understanding of side effects resulting from cancer immunotherapy treatments, and tie to our other Cancer Immunotherapy Guidelines and recommendations, including the combination immunotherapies white paper and Immune Biomarkers Task Force white papers.

These are just a few recent examples of SITC meetings and initiatives that impact the field receiving both scientific and popular press support and attention. We look forward to finding new and innovative ways for SITC and our members to continue leading the way in cancer immunotherapy research.

Best wishes,

butterfield_preferred_profile-pic

Lisa H. Butterfield, PhD

SITC President

Education
SITC IMMUNO-ONCOLOGY SPRING WORKSHOPS - MARK YOUR CALENDARS! 

Mark your calendars to attend SITC's spring workshops, to be held in San Francisco, CA. Registration will open soon.

Cancer Immune Responsiveness Workshop – May 14-15, 2018
This workshop promises to be a dynamic and lively opportunity to help determine which questions in cancer cell biology must be answered in order to understand patterns of immune interaction between the host and cancers of different ontology. Topics slated for discussion include the role of the host's genetic background and/or environmental modifiers in cancer immune biology, the role of adaptive versus innate immune mechanisms in initiating immune activation, and the development of improved in vivo models for screening therapeutic strategies.

Over the course of the two-day workshop, participants will attend five didactic sessions, each followed by an interactive panel discussion, and later split into working groups tasked with refining and prioritizing key questions identified. By contributing to defining pivotal questions in cancer immune responsiveness/resistance, participants will help deepen understanding of the cancer biology that orchestrates distinct immune landscapes, and help move the field towards improved therapeutic strategies.

Following the workshop, the SITC Cancer Immune Responsiveness Task Force will convene five working groups, incorporating workshop attendees, to address these key questions in the years ahead.

Learn more about this workshop here, and keep your eyes open for a 'registration now open' announcement coming soon.

Immuno-Oncology Biomarkers: State of the Art – May 16-17, 2018
SITC will have representation from academia, clinical medicine, government, industry and others in the cancer immunotherapy community to drive discussion during the Immuno-Oncology Biomarkers: State of the Art workshop, which runs back-to-back with the Cancer Immune Responsiveness Workshop (above).

The Immuno-Oncology Biomarkers workshop will identify the next steps for action in immunotherapy biomarker development. It will provide a forum for energetic discussion about the collaborative efforts across several societies and consortia, make progress on identification and analysis of novel biomarkers, and tackle data analysis and specimen sharing. The final session will bring together representatives from the fields of immune-oncology research, infectious disease, autoimmune disease and cell biology to discuss opportunities for cross-disciplinary collaboration to advance biomarker development.

Panel discussions following each didactic presentation will allow all participants to contribute to the conversation, and to shape the innovative collaborations, next projects and other outputs that the SITC Immune Biomarkers Task Force will incorporate over the next several years.

Learn more about this workshop here and join us to advance the conversation!

INTRODUCTORY CANCER IMMUNOTHERAPY EDUCATION NEAR YOU

Attend a regional introductory immunotherapy education program in your area and earn CME, CNE, and CPE credits. Find an Advances in Cancer Immunotherapy™ program location near you and visit our site for details about the programs and how to register.

• Feb. 9, 2018 – Durham, NCaci17-cmyk.png
• Feb. 24, 2018 – Charleston, SC
• March 3, 2018 – Dallas, TX
• March 10, 2018 – Miami, FL
• March 24, 2018 – Buffalo, NY

Science, Research & Publications

CALL FOR PAPERS: JITC NOW WELCOMING SUBMISSIONS ON THREE KEY TOPICS

JITC_logo.pngNow through March 2, 2018, JITC welcomes submissions on the topics of Emerging Immunotherapeutic Agents, New Regulatory Approvals in Cancer Immunotherapy, and Challenges in Clinical Management. Articles submitted will be reviewed for publication within a dedicated thematic series, providing even greater opportunity for your research to reach cancer immunotherapy leaders and administrators throughout the world. 

Full details and submission guidelines may be found here.

"ADVANCING THE FIELD: CAN PHYSICS AND MATHEMATICS IMPACT THE DEVELOPMENT OF TUMOR IMMUNOTHERAPY?" REPORT FROM SITC 2017 NOW AVAILABLE! 

A report from the final "Hot Topic" session of the SITC 2017 Annual Meeting is now available on SITC CONNECT. This session, entitled Advancing the Field: Can Physics and Mathematics Impact the Development of Tumor Immunotherapy? brought together leading experts in tumor immunology, applied mathematics and theoretical physics to explore how knowledge from these disciplines can be assimilated to advance tumor immunotherapy. The goals of this cross-functional session were to define some of the most important questions in immune-oncology and to identify how the emerging fields of "immuno-physics" and "immuno-mathematics" can drive progress in understanding tumor immunology and immunotherapy.

Read a summary of the session, as well as the panel Q&A, here.
A webcast of the session is also available here.

 Membership

JOIN THE LEADERS IN CANCER IMMUNOTHERAPY RESEARCH!

2017 was an exciting year for critical breakthroughs in the field of cancer immunotherapy research and SITC played a pivotal role in leading the way! As a SITC member, you join a collaborative global network of scientists, clinicians, academicians, patient advocates and industry leaders who are revolutionizing the future of cancer care and bringing us closer to a cure.

Join or renew to take advantage of member benefits including:

There hasn't been a better time to be a SITC member!

Join_SITC_IM.jpg


Renew_Button_blue.jpg
WELCOME NEW MEMBERS DEC. 1 THRU DEC. 31

Thank you to those who joined the society in the month of December. If you are a SITC member, please welcome the following new members by sending a message of congratulations through the SITC CONNECT Member Directory.

Bilqees Akhtar, MS, MPH

Joaquina C. Baranda, MD

Pia Baumann, MD, PhD

Frank Borriello, MD, PhD

Michelle S. Buluran, RN

Sanjay Chandrasekaran, MD

Peter Georgiev

Jaymee Grape, RN

James D. Ham

Tobias A.W. Holderried

Weidong Huang, PhD

Rowena Jeves, RN

David M. Miller, MD, PhD

M. Cecilia Monge B., MD

Su Youn Nam, MD, PhD
Nandakumar Packiriswamy, PhD
Scott Rowlinson, PhD
Kit Russell, BS
Igor Rybkin, MD, PhD
Arvind Sivasubramanian
Karen Skinner, PhD
Johnny T. Stine, CSO
Giselle A. Suero-Abreu, MD, PhD
Czarina Marie S. Villanueva, RN
Bei Wang, PhD
Paul Wood, BSc
Chueh-Chuan Yen, MD, PhD

 

Forward Fund

SITC FELLOWSHIP SUBMISSIONS NOW BEING ACCEPTED THROUGH FEB. 20, 2018
Fellowship_logo_lg.png

The Society for Immunotherapy of Cancer's (SITC) Fellowship award program was established through the Forward Fund to cultivate the next generation of cancer immunotherapy experts by supporting the development of young investigators in the field. Since 2014, SITC has committed more than $1 million in fellowship awards to deserving young investigators. 

SITC is pleased to announce three new fellowships in 2018:

  • SITC-Bristol-Myers Squibb Postdoctoral Cancer Immunotherapy Translational Fellowship Award
    - Two Years, $200,000
  • SITC-AstraZeneca Postdoctoral Cancer Immunotherapy in Combination Therapies Clinical Fellowship Award
    - One Year, $100,000
  • SITC-Merck Cancer Immunotherapy Clinical Fellowship Award
    - One Year, $100,000

For more information on the 2018 fellowships click here.

THANKS TO YOUR GIFTS, WE'RE MOVING CLOSER TO A CURE!   

Contributions to the Forward Fund in 2017 helped to support 88 early career scientists as they pursued critical new discoveries to advance the field of cancer immunotherapy.

Because of your generosity, we also met the $300,000 challenge grant and launched the inaugural Sparkathon. Please accept our sincere gratitude for helping to make these important milestones possible.

If you did not get an opportunity to make your gift in 2017, we welcome you to make your gift today as we continue our commitment to make cancer immunotherapy a standard of care - and CURE a reality for patients everywhere! 


sparkathon-donate-btn-v2.jpg
2017 FORWARD FUND DONORS
Giovanni Abbadessa
Ulrika B. Abrahamsson
Estuardo Aguilar
Anna Ajeskog
Srinivas Akkaraju
Ivy Altomare
Amazon Smile
Amgen Inc.
Athanasia Anognostou, MS, MBA
Christina M. Annunziata, MD PhD
Anonymous
Jennifer Antonucci
Osvaldo Aren, MD
Gladys Arreaza
Banu Arun
AstraZeneca Pharmaceuticals LP
Kate Augustine
Johana Austria, NP
Steve Averbuch
Shara Avis
Joseph Baar, MD, PhD
Karen Bagwell
Adam Barrows
Paul Basciano, MD
Reva Basho
Andrea Basso-Porcaro, PhD
Riyue Bao, PhD
John W. Beadle, MBBCH
Davide Bedognetti MD, PhD
Darlene Beltran, MBA
Yong Ben, MD
Soumaya Bendahmane
Adrian Benjamin
Jonathan Benjamin, MD, PhD
Christopher Berardi
Tara Berman
Chantale Bernatchez, PhD
Elmer Bernstam
Dhara Bhagat
Nina Bhardwaj MD, PhD
William A. Biermann, MD, MBA, FACP
Praveen K. Bommareddy, MS, BS
Heather Bonsiero
Mark L. Bonyhadi, PhD
Andrew Boone, MBA
Hossein Borghaei, MS, DO
Deb Braccia
Kerry Bradley
Silke Brandt-Schmidt
Robert Braun
Michael J. Briskin, PhD
Dirk G. Brockstedt, PhD
Andrew S. Brohl, MD
Joseph Brougham, PharmD
Beatrice A. Brunkhorst, PhD
Damani Bryant
Thomas A. Buchholz, MD FACR FASTRO
Ian Buell
Michaeline Bunting
Jonathon Burch, PharmD
Joseph Burgents, PhD
Robert A. Burger
Melissa Burgess, MD
Beth Burnett
Lisa H. Butterfield, PhD
Martin Butzal
Neil Canavan
Ana Carneiro, MD PhD
Omar Carranza
Peggy Carroll
Corey Carter
Marianne E. Casale, MSN, RN, AOCNS, CHPN
Eli Casdin
Henry Castro, MD
CEC Oncology
Alessandra Cesano, MD, PhD
Chanty Chan
Swapna Chandamuri
Deborah Charych, PhD
Gurkamal Chatta, MD
Martin A. Cheever, MD
Jonathan Chen
Adam Chervin, PhD
Ann Cheung, PhD
Helen Cho, PhD
Tara Chongsuwat
Olaf Christensen
Mary Christian
Joseph I. Clark, MD
Raphael Clynes, MD, PhD
Heather Cohen, PhD
Yael Cohen
Adriana Comprelli
Anthony P. Conley, MD
Sarah Cooley, MD
Andrea Cotton-Berry
Tim Cox
Marka Crittenden, MD, PhD
Nicolas Cuburu, PhD
Brendan D. Curti, MD
Carin Dahlberg
William Dahut, MD
Kevin Dai
Christina Dailey
Kelly Daily
Eileen Daniel
Deanna Darlington
Mary Ella Davidson
Sophia C. Davis
Tanja De Gruijl, PhD
Olivier De Henau, MD
Sandra Demaria, MD
Mark Dempsey
Garrett DeYulia, PhD
Mohanraj Dhanabal, PhD
Muthu Dhandapani, MS, CMDP
Adam Dicker, MD, PhD
Mary Dominiecki, PhD
Taral Doshi
Joseph J. Drabick, MD, FACP, FIDSA
Charles G. Drake, MD, PhD
Thomas W. Dubensky Jr., PhD
Kevin T. Duffy, PhD, MBA
Reinhard Dummer, MD
Emma Eaves
Diane Eckermann
Lisa Maria Eifler, RN, MA, MN, OCN
Peter Ellmark, PhD
Mohamed Elshawarby, BA
George Elston
EMD Serono, Inc.
Leisha A. Emens, MD, PhD
Niels Emmerich, PhD
Marlene Erickson, BS
Richard Erickson
Zeynep Eroglu
Sonia Espana
Pamela Esposito, PhD
Tullio V. Esposito
Cesar Evaristo, PhD
Mitchell Ezra
Jeanne M. Fahey
Justin Fairchild
Allam A. Fakhoury, PharmD
Michael J. Fallon, MD, MBA
Jim Feeney, MBA
Irina Fernandez Curbelo, PhD
Robert L. Ferris, MD, PhD
Ricarda Finnern, PhD
Melissa Fitzgerald
Blake Flood
Silvia Formenti, MD
Martin Forster
Bernard A. Fox, PhD
Floyd E. Fox, PhD
Kammi L. Fox-Kay
Gordon Freeman, PhD
Kimberly Freeman
Michael J. Frezza, PhD
Julie Frinzi
Steven Frommeyer
Jami Fukui
Jason Fuller
Thomas F. Gajewski, MD, PhD
Carol G. Gallagher, PharmD
Tara C. Gangadhar, MD
Marie-Claude Gaudreau, PhD
Yona Geffen
Tara Gehring, RN, BSN, OCN
Mark S. Gelder, MD
Genentech
Michael A. Gentile, PhD
Catherine Gerbon
Geoffrey T. Gibney, MD
Daniel Giglio
Deb Gilbertson, MS
Tim Gioia
Laura Goldie
Jesus Gomez-Navarro, MD
Neal Goodwin
Jasmine Greenamyer, MPH
Beth Gregory, PharmD, MBA
Nancy Gregory, RN, BSN
Asya Grinberg
Christine Grossman
John Grous, MD
Jean Gudas, PhD
Joseph Guidi
James L. Gulley, MD, PhD, FACP
Elisa Guo, MBA
Ramon Gutierrez, MD
Jane Gutkovich
Cheryl A. Guyre, PhD
Tetsuya Hagiwara
Kim  Hamilton
John P. Hanson, Jr., MD
Masahiro Hara
Fiona Harding, PhD
Kimberly Harrow, MBA
Christopher Harvey
Jessica Hayes
Margareta Heby
Amir Hefni, PhD
Kristen Hege, MD
Kevin Heller, MD
Meliessa Hennessy, MPH
Pia Herbolsheimer
Charles Hesdorffer, MBBCh, MMED
Joshua Hildebrand
Art Hirt
F. Stephen Hodi Jr., MD
Christoph Hoeller
Adi Hoess
Kate Hohenberg
William Hokanson
Kroenig Holger
Joe Horvat
Lori Hu
Nageatte Ibrahim, MD
Thomas Ichim, PhD
Incyte Corporation
Hidenobu Ishizaki, MD
John E. Janik, MD
William Earl Janssen, PhD
Klaus Jeschke
Patti Jewell
Karin Jirstrom
Reed Jobs
Bryon D. Johnson, PhD
Jennifer Clare Jones, MD, PhD
Kristi Jones, PharmD
Carl H. June, MD
Harini Kandadi
Aaron Kantoff
Maria Karasarides, PhD
Gabor Kari, MD
Mark Kaplan
Per Karlsson
David Kaufman, MD, PhD
Howard L. Kaufman, MD, FACS
Susan Kelley, DO
Richard Kenney, MD
Seckar Khaldoyanidi
Samir N. Khleif, MD
Ben KiefelSungwuk Kim
Masanobu Kimura
Michael King, BA
Pam M. Klein, MD
Victor Kleinman
Kathleen Kokolus, MS, PhD
Marie-Eve Koziol, BA
Marcy Kravet
Lynne Krayer-Luke
Carsten Krieg, PhD
Anuja Kriplani
Rebecca Kristeleit
Stew Kroll
Marie Kromplewski
Jeremy Kuperberg
Stephan Kusick
Chrisann Kyi, MD
Anna Labrosciano
Mark Landers, MS
Chrystal Landry, MD
Maureen E. Lane, PhD
Denise Lapka, MSN, AOCN
Walter Lau, PhD
Colleen Lawlor
Julia Lawrence
Rachel Layman, MD
Rimma Lebedev
Rom Leidner, MD
Shawn M. Leland, RPH
Claudia Lennicke
Zurit Levine
William R. Levis, MD
Kate Levitov
Carmen Lilla
Jonathan Lim
Shelby Lipton
Jennifer Litton, MD
Yi Liu
Aaron Llanso
Cecile Lloret
Andrey Loboda, PhD
Anne Lodge, PhD
Wolfgang Loidl
Nils Lonberg, PhD
Michael T. Lotze, MD
Vanessa M. Lucey
Jason Luke, MD
Jose Lutzky, MD, FACP
Jaclyn P. Lyman, MSc
Joanne Lynch
Brendan W. MacNabb
Heather Maecker, PhD
Elizabeth Maggio, PhD, RN
Syam Prasad Mallampalli, MD, MPH
Stefanie J. Mandl, PhD
Michael Mandola
Nataly Majarrez Orduno
Kimberley Maplestone
Upendra Marathi, PhD, MBA
Ariel E. Marciscano, MD
Kim A. Margolin, MD
Thomas Marron, MD PhD
Louis Matis, MD
Marcela V. Maus, MD, PhD
Necia Maynard, APRN-BC, AOCNP
Ian McCaffery, PhD
Terri Mcclanahan
Mary McGinley
Tracy McGowan
George McNamara
Shikhar Mehrotra, PhD
Monal Mehta
Roland Meier, MD, PhD
Christopher Melani
Ignacio Melero, MD, PhD
Dave Melin
Georgina Menyah
Olivier Michielin, MD PhD
Mari Mino-Kenudson, MD
Cliff Miras
Benedikt Moenig
David Moffat, PhD
Melissa Moles
Klaus-Dieter Molle
Paul Moore, PhD
Carl D. Morrison, MD, DVM
George Morstyn, MD, PhD
Stergios Moschos
David Mott
Tarsem Moudgil
Stacy Moulder
John T. Mulligan, PhD
Shinobu Murakami
Sally Murphy
Barry Murtaugh
Sara Musalli
Yana G. Najjar, MD
NanoString Technologies
Stephanie Narain
Yoshinori Narita, PhD
Chandrasekhar Natarajan
Joel Neal, MD, PhD
Jaclyn Neely, PhD
Edward L. Nelson, MD
John Newman
Rachel  Newman
Dora Niedersuess
Scot A. Niglio, MD
Marius Normann
Marta Nyakas
Toshiaki Ohtsuka, PhD
Laureen Ojalvo, MD, PhD
James O'Keefe
Hideho Okada, MD, PhD
Alex Olawaiye, MD
Martin Olivo
Claudia D. Onofrei, MD
Keith Orford, MD, PhD
Kelly Ostrander
Willem W. Overwijk, PhD
Russell Pachynski, MD
Sukhmani K. Padda, MD
Penny Papastathis
Drew M. Pardoll, MD, PhD
Wungki Park, MD
Namrata S. Patil
Akash Patnaik, MD, PhD
Chrystal Paulos, PhD
David J. Peace, MD
Tillman Pearce, MD
Eduardo J. Pennella, MD
Nathan D. Pennock, PhD
Serena K. Perna, MD
Istvan Petak
Tara Petersen
Caryn Peterson
Abdulmohammad Pezeshki, PhD
Pfizer, Inc.
Martin Picard
Robert H. Pierce Jr., MD
Jan Pintoffl, MD
Christian H. Poehlein, MD
Kathy Q. Porter
Michael Postow, MD
Susan E. Predaris, RN, MPH
Anna Prince
Thomas Przybysz, MD
Igor Puzanov, MD, MSCI, FACP
Willie Quinn
Laszlo G. Radvanyi, PhD
Murali Ramachandra, PhD
Suresh S. Ramalingam, MD
Sophia Randolph, MD, PhD
Arjun A. Rao
Elias Rawad
Jigar Raythatha
Olivia Razo
Paul Rennert
Elizabeth A. Repasky, PhD
Frederic Reu
Antoni Ribas, MD, PhD
Andrea Rindo
David A. Rizzieri, MD
Charles Roberts
Paul B. Robbins, PhD
Juli Robinson
Jordi Rodon
Lars Roese, PhD
Clare Rogers, MS
Cristhian Rojas Hernandez, MD
Pedro J. Romero, MD
John M. Rossi
Marcel Rozencweig
Lindsay Ryland, PhD
Mariana Sacchi
Abdel Saci
Michel Sadelain, MD, PhD
Gunnar Saeter, MD, PhD
Martha Salas
Rachel Salazar, MS PMP
Rachel E. Sanborn, MD
Jacob Sands
Miguel F. Sanmamed, MD, PhD
Sriram Sathy, PhD
Pooja Sawhney
Kurt A. Schalper, MD, PhD
Todd D. Schell, PhD
Doris Schuchter
Florian Schuster
Christina Seckar
Oscar Segurado, MD, PhD
Jonathan S. Serody, MD
Kimberly A. Shafer-Weaver, PhD
Amishi Shah
Steven A. Shak, MD
Lisa Shames
Kandavel Shanmugam, PhD
Mark Shapiro
Michele Sharr-McMahon, MS
Denise R. Shaw, PhD
Heather Shaw
Dawne Shelton
Stephen A. Sherwin, MD
Wen Shi, MD, PhD
Kentaro Shinohara, PhD
Xiao Shu
R. Alejandro Sica, MD
Tsiogkas Sideris
Elliott Sigal, MD
Harpreet Singh, PhD
Manish Singh, PhD
Troy Siragusa
Marko Sirkia
Jeremy Smith
Linda Snyder, PhD
Heather M. Sonnemann
Dirk Spitzer, PhD
Stefani Spranger, PhD
Manuel Spulveda
Marianne Stanford, PhD
Andreas Stepan
Tom Li Stephen, PhD
Ulrika Stierner
Johnny T. Stine, CSO
Jesse A. Stoff, MD
Howard Streicher, MD
Sumit K. Subudhi, MD, PhD
Randy F. Sweis, MD
Mario Sznol, MD
Barbara Szymaszek
Wendy Tai
Raymond Tabibiazar
Jun Tang, PhD
Yun-Hsin Tang, MD
Thelma R. Tennant, PhD
Cherry T. Thomas, MD
Alastair Thompson
Beth Thompson
John M. Timmerman, MD
Suzanne L. Topalian, MD
Dan Trafton
Lindsay Treadway
Lois Trench-Hines
Catherine Tribouley, PhD
Nicholas Tschernia
Apostolia M. Tsimberidou, MD, PhD
Geeta Upadhyay, PhD
Pablo Urbaneja
Megumi Uzu
Mike Van Alstine
Vamsidhar Velcheti, MD
Rajwanth Veluswamy
Carol T. Verser, PhD
Dario A. A. Vignali, PhD
Patrik Vitaka
Alberto C. Vitari, PhD
Viviana Volta, PhD
Heidi C. Vosseler, RN
Dorothy M. Waddell
Eric Walk, MD, FCAP
Ian Walters, MD
Roger J. Waltzman, MD, MBA
Masaru Wananbe
Li-Hsien Wang, PhD
Young Wang, MD, FACB
George J. Weiner, MD
James W. Welsh, MD
Susan K. Welsh
Marjorie T. West
Genevieve White
Oliver M. Wilbert, MS, PhD, MBA
Jonathan Wilcox
Jason B. Williams
Anna Winge-Main
Tara Withington, CAE
Cynthia Wojtaszek
Cynthia Wong
Michael K. Wong, MD, PhD, FRCPC
Jack Wu
Clinton Yam
Richard K. Yang, Md, PhD
Xiaodong Yang, MD, PhD
Cassian Yee, MD
Michael Yellin, MD
Bing Yuan, PhD
Ashley Yum
Pat Yuzawa-Rubin
Alberto Zacarias, MS, MBA
Julie Zaidler, MS
Michael Zanoni
Eva Zavadova, MD, PhD
George B. Zavoico, PhD
Chenggang Zhu
Janice Zilisch, PhD
Lauren Zoeller
Dieter Zopf
In Honor of Dr. Rachel Wallach Humphrey
Carolyn and Aron Rosenberg
Lee and Marilyn Wallach
In Honor of Mr. Harry T. Lester
Whitney Lester
In Memory of Kenneth F. Anderson, MD 
Elizabeth Anderson
Kenneth T. Anderson
Kristin Anderson, PhD
Graham Andrews
H. Ann Bole
Timothy & Beth Dougherty
Denise Howell
Kevin & Rachel McGinnis
Gene & Jan Morabito
John & Suzanne O'Malley
Maryanne Pavloff
The Pickell Family
Lawrence & Patricia Skahan
Richard & Dorothy Thompson
In Memory of Mrs. Meenakshi Bhandarkar 
Supriya Pai, PhD
In Memory of Mr. Alvin de Guzman
Erlinda M. Gordon, MD
In Memory of Dr. Robert Friefeld
Patrick Deem
Jalynne Figueroa
Angelica E. Gunderson
Jennifer and Nathan Hayward
Nina Nash
Rebecca Schwartz
The Skara Family
Nancy and Mark Smith
Cynthia Walter
Brad and Dona Walters
In Memory of Mrs. Natasha Powderly 
Nicholas Adamczak
Michael A. Blair
Patricia A. Brophy
John & Beth Crowder
Ken DePorter
Craig Durosko
Marc and Cindy Eisenbaum
Anne Flannagan
Scott and Wendy Gedicks
Geraldine B. Hall
Karen Har Druffel
Kelly C. Hoffman
Matthew P. Kiefaber
Marie Kiper
Janelle Peters
Gerald Powderly
Robert and Anne Powderly Foundation
Sandra Saltz
Laura Seal
Joe & Mandie Staley
David and Karen Viar
Cassi L. Walls
Paige Pistell Witte
In Memory of Mrs. Dottie Snodgrass
Jeff and Angie Kahn
Chris & Margo Wilcox